 SINGAPORE, Feb. 18, 2021 GLOBE NEWSWIRE -- ASLAN Pharmaceuticals Nasdaq:ASLN, a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the appointment of Neil Graham, MBBS, MD, MPH as an independent director. Dr Graham, an expert in immunology and inflammation, has more than 30 years experience in global drug development and commercialisation, traversing early and late-stage clinical trials in dermatology, allergy, rheumatology, virology, and pulmonology. Dr Graham is currently Chief Medical Officer of Tiziana Life Sciences plc Nasdaq:TLSA, AIM:TILS and a director of Pharmaxis Ltd. 